Dark
Light
System
Institutional Investment Manager
Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB (CIK: 0001599882), located at Strandvagen 5a, Stockholm. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q4)
Portfolio Summary: 108 holdings with a total value of $521,630,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 THRESHOLD PHARMACEUTICAL INC 201,537 89,000 0.02%
2 OPHTHOTECH CORP 23,920 116,000 0.02%
3 ANTHERA PHARMACEUTICALS I 200,000 130,000 0.02%
4 CATERPILLAR INC 1,548 144,000 0.03%
5 OREXIGEN THERAPEUTICS INC 120,000 209,000 0.04%
6 ANHEUSER BUSCH INBEV SA/NV 2,180 230,000 0.04%
7 MIRATI THERAPEUTICS INC COM 50,000 238,000 0.05%
8 HALLIBURTON CO 4,931 267,000 0.05%
9 QUALCOMM INC 4,126 269,000 0.05%
10 FORD MTR CO DEL 22,511 273,000 0.05%
11 EXXON MOBIL CORP 3,195 288,000 0.06%
12 INTERNATIONAL BUSINESS MACHS 1,766 293,000 0.06%
13 MICROSOFT CORP 4,793 298,000 0.06%
14 CONCERT PHARMACEUTICALS INCORPORATED 30,099 310,000 0.06%
15 STAAR Surgical Co 28,711 312,000 0.06%
16 OCULAR THERAPEUTIX INC 40,000 335,000 0.06%
17 WELLS FARGO & CO NEW 6,118 337,000 0.06%
18 JPMORGAN CHASE & CO 4,087 353,000 0.07%
19 Catabasis Pharmaceuticals Inc 100,000 361,000 0.07%
20 MYLAN N V 10,000 382,000 0.07%
21 ADVERUM BIOTECHNOLOGIES INC 154,006 447,000 0.09%
22 TANDEM DIABETES CARE INC COM 234,000 503,000 0.10%
23 MEDNAX INC 9,000 600,000 0.12%
24 ACHILLION PHARMACEUTICALS IN 166,000 686,000 0.13%
25 BECTON DICKINSON & CO 5,000 828,000 0.16%
26 REGULUS THERAPEUTICS INC COM 468,175 1,053,000 0.20%
27 TETRAPHASE PHARMACEUTICALS INC COM 300,000 1,209,000 0.23%
28 INSULET CORPORATION 35,000 1,319,000 0.25%
29 AERIE PHARMACEUTICALS INC COM 35,000 1,325,000 0.25%
30 NEUROCRINE BIOSCIE COM USD0.001 40,000 1,548,000 0.30%
31 HALOZYME THERAPEUTICS INC 180,000 1,778,000 0.34%
32 CHIMERIX INC 400,000 1,840,000 0.35%
33 DYNAVAX TECHNOLOGIES CORP 485,000 1,916,000 0.37%
34 ILLUMINA INC 15,000 1,921,000 0.37%
35 ACADIA PHARMACEUTICALS INC COM 70,000 2,019,000 0.39%
36 WALGREENS BOOTS ALLIANCE INC 25,000 2,069,000 0.40%
37 PERRIGO CO PLC 25,000 2,081,000 0.40%
38 RADIUS HEALTH INCORPORATED COM NEW 55,000 2,092,000 0.40%
39 INTERCEPT PHARMACEUTICALS INCORPORATED 20,000 2,173,000 0.42%
40 ADAMAS PHARMACEUTICALS INC 130,000 2,197,000 0.42%
41 FIBROGEN INC 104,000 2,226,000 0.43%
42 KERYX BIOPHARMACEUTICALS INCORPORATED 425,111 2,491,000 0.48%
43 TESARO INCORPORATED 20,000 2,690,000 0.52%
44 PORTOLA PHARMACEUTICALS INC 120,805 2,711,000 0.52%
45 DAVITA INC 45,000 2,889,000 0.55%
46 RIGEL PHARMACEUTICAL INC 1,282,000 3,051,000 0.58%
47 COHERUS BIOSCIENCES INC COM 111,357 3,135,000 0.60%
48 NEURODERM LTD 142,546 3,165,000 0.61%
49 MACROGENICS INC 155,000 3,168,000 0.61%
50 UNIVERSAL HLTH SVCS INC 30,000 3,191,000 0.61%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-17-000078, filed 2017.01.13).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.